Pharmacotherapetic analysis of users of a psychosocial care
International Journal of Development Research
Pharmacotherapetic analysis of users of a psychosocial care
Received 03rd October, 2019; Received in revised form 17th November, 2019; Accepted 26th December, 2019; Published online 29th January, 2020
Copyright © 2020, Tagmi Joaquim Ialá et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The use of psychotropic drugs has increased in recent decades, and this growth can be attributed to the higher frequency of diagnoses of psychiatric disorders in the population, the introduction of new drugs in the pharmaceutical market and the new pharmacotherapeutic indications. The objective of this study was to analyze the pharmacotherapeutic profile of users seen at the Psychosocial Care Center (CAPS I) in the city of Redenção - CE. Thus, it was a cross-sectional descriptive and documentary analysis study with a quantitative approach. Data collection occurred from July 2018 to February 2019, were made through a form prepared by the researchers that served as support to obtain information about the sociodemographic profile, information regarding the drugs used and treatment time. An actual sample of 169 medical records was analyzed. It was found that 120 (71%) are women and 49 (29%) are men, with ages ranging from 18 to 59 years. The most prescribed psychotropic classes were antipsychotics, especially haloperidol (13.70%), followed by amitriptyline antidepressant (6.70%). Thus, it was concluded that the highest percentage of users are women who attend CAPS and are treated with psychotropic drugs. Antipsychotics were the most prevalent psychotropic drugs, which may reflect the increased diagnosis of psychic disorders.